Is BPC-157 legal?
Medically reviewed by Dr. Jonathan Snipes, MD
Reviewed for clinical accuracy · Last reviewed July 22, 2026 · Review policy
Quick answer
BPC-157 is not FDA-approved. It has been available through compounding and the research-chemical market, but its compounding pathway is under formal FDA review at the July 2026 PCAC meeting, where the agency recommended against listing it.
- FDA status
- Not FDA-approved; compounding under FDA review (July 2026)
- Prohibited in sport (WADA)
- Yes
BPC-157 is not an FDA-approved drug. It has circulated through two channels: prescription compounding at licensed pharmacies, and the unregulated research-chemical market, where it is sold as 'not for human use.' It is prohibited in sport under the WADA framework.
Its regulated status is actively changing. BPC-157 is one of seven peptides the FDA's Pharmacy Compounding Advisory Committee reviewed on July 23, 2026, for the 503A Bulks List, and the FDA's briefing documents recommended against adding it. That vote is advisory and the FDA issues the final decision separately, but if an exclusion is finalized, the licensed-compounding route would close and access would move further into the unregulated market.
Frequently asked questions
Is BPC-157 legal in the US?+
BPC-157 is not FDA-approved. It has been available through compounding and the research-chemical market, but its compounding pathway is under formal FDA review at the July 2026 PCAC meeting, where the agency recommended against listing it.
Do you need a prescription for BPC-157?+
BPC-157 is not FDA-approved. Where it is available through a compounding pharmacy it requires a prescription; research-chemical versions are sold outside the regulated, prescription-based system.